Follicular variant of papillary thyroid carcinoma: Genome-wide appraisal of a controversial entity Journal Article


Authors: Wreesmann, V. B.; Ghossein, R. A.; Hezel, M.; Banerjee, D.; Shaha, A. R.; Tuttle, R. M.; Shah, J. P.; Rao, P. H.; Singh, B.
Article Title: Follicular variant of papillary thyroid carcinoma: Genome-wide appraisal of a controversial entity
Abstract: The majority of thyroid tumors are classified as papillary (papillary thyroid carcinomas; PTCs) or follicular neoplasms (follicular thyroid adenomas and carcinomas; FTA/FTC) based on nuclear features and the cellular growth pattern. However, classification of the follicular variant of papillary thyroid carcinoma (FVPTC) remains an issue of debate. These tumors contain a predominantly follicular growth pattern but display nuclear features and overall clinical behavior consistent with PTC. In this study, we used comparative genomic hybridization (CGH) to compare the global chromosomal aberrations in FVPTC to the PTC of classical variant (classical PTC) and FTA/FTC. In addition, we assessed the presence of peroxisome proliferator-activated receptor-gamma (PPARG) alteration, a genetic event specific to FTA/FTC, using Southern blot and immunohistochemistry analyses. In sharp contrast to the findings in classical PTC (4% of cases), CGH analysis demonstrated that both FVPTC (59% of cases) and FTA/FTC (36% of cases) were commonly characterized by aneuploidy (P = 0.0002). Moreover, the pattern of chromosomal aberrations (gains at chromosome arms 2q, 4q, 5q, 6q, 8q, and 13q and deletions at 1p, 9q, 16q, 17q, 19q, and 22q) in the follicular variant of PTC closely resembled that of FTA/FTC. Aberrations in PPARG were uniquely detected in FVPTC and FTA/FTC. Our findings suggest a stronger relationship between the FVPTC and FTA/FTC than previously appreciated and support further consideration of the current classification of thyroid neoplasms. © 2004 Wiley-Liss, Inc.
Keywords: immunohistochemistry; adult; cancer survival; aged; middle aged; major clinical study; chemical analysis; gene amplification; tumor differentiation; carcinoma, papillary; genetic variability; chromosome aberration; genome analysis; dna, neoplasm; thyroid neoplasms; chromosome aberrations; nucleic acid hybridization; tumor growth; chromosome deletion; comparative genomic hybridization; peroxisome proliferator activated receptor gamma; aneuploidy; thyroid papillary carcinoma; thyroid tumor; cytogenetic analysis; genome, human; carcinoma, papillary, follicular; thyroid follicular carcinoma; southern blotting; variation (genetics); humans; human; male; female; priority journal; article
Journal Title: Genes Chromosomes and Cancer
Volume: 40
Issue: 4
ISSN: 1045-2257
Publisher: Wiley Periodicals, Inc  
Date Published: 2004-08-01
Start Page: 355
End Page: 364
Language: English
DOI: 10.1002/gcc.20049
PROVIDER: scopus
PUBMED: 15188460
DOI/URL:
Notes: Genes Chromosomes Cancer -- Cited By (since 1996):43 -- Export Date: 16 June 2014 -- CODEN: GCCAE -- Source: Scopus
Altmetric
Citation Impact
BMJ Impact Analytics
MSK Authors
  1. Ronald A Ghossein
    482 Ghossein
  2. Ashok R Shaha
    695 Shaha
  3. Bhuvanesh Singh
    242 Singh
  4. Robert M Tuttle
    479 Tuttle
  5. Jatin P Shah
    718 Shah
  6. Michael Hezel
    19 Hezel